Clearpoint Neuro Inc
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser cat… Read more
Clearpoint Neuro Inc (CLPT) - Total Liabilities
Latest total liabilities as of September 2025: $44.48 Million USD
Based on the latest financial reports, Clearpoint Neuro Inc (CLPT) has total liabilities worth $44.48 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Clearpoint Neuro Inc - Total Liabilities Trend (2011–2024)
This chart illustrates how Clearpoint Neuro Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Clearpoint Neuro Inc Competitors by Total Liabilities
The table below lists competitors of Clearpoint Neuro Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alma Media Oyj
HE:ALMA
|
Finland | €271.90 Million |
|
EuBiologics Co. Ltd.
KQ:206650
|
Korea | ₩58.92 Billion |
|
Harworth Group plc
PINK:HWGLF
|
USA | $358.73 Million |
|
AES Brasil Energia S.A
SA:AESB3
|
Brazil | R$14.99 Billion |
|
Continental Holdings Corp
TW:3703
|
Taiwan | NT$67.03 Billion |
|
Aviat Networks Inc
NASDAQ:AVNW
|
USA | $387.74 Million |
|
Beijing Huaru Technology Co. Ltd.
SHE:301302
|
China | CN¥297.63 Million |
|
Zhejiang Zuch Technology Co. Ltd. A
SHE:301280
|
China | CN¥775.59 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Clearpoint Neuro Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Clearpoint Neuro Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Clearpoint Neuro Inc (2011–2024)
The table below shows the annual total liabilities of Clearpoint Neuro Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $13.80 Million | -35.78% |
| 2023-12-31 | $21.49 Million | +15.51% |
| 2022-12-31 | $18.60 Million | +10.77% |
| 2021-12-31 | $16.79 Million | -38.12% |
| 2020-12-31 | $27.14 Million | +269.72% |
| 2019-12-31 | $7.34 Million | +15.68% |
| 2018-12-31 | $6.35 Million | -21.35% |
| 2017-12-31 | $8.07 Million | -1.08% |
| 2016-12-31 | $8.16 Million | -32.50% |
| 2015-12-31 | $12.08 Million | -10.40% |
| 2014-12-31 | $13.49 Million | -8.30% |
| 2013-12-31 | $14.71 Million | +30.28% |
| 2012-12-31 | $11.29 Million | -54.62% |
| 2011-12-31 | $24.87 Million | -- |